The group said it has implemented pricing in some of the schemes that are underperforming and continues to ensure that each and every scheme becomes profitable and sustainable on its own.
Botswana’s recent shortage of chronic medication in some parts of the country is more than a health story. It has real implications for Botswana Insurance Holdings Limited (BIHL), and by extension investors.
This post is only available to members. To access this post, you must subscribe.
